EUVIMEDEUVIMED entdecken
Crossref

The National Health Service 2-week-wait skin cancer referral pathway: analysis and recommendations for process improvement

Vishal Madan

Clinical and Experimental Dermatology · 2024

DOI: 10.1093/ced/llae323 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, 2024. Verfasst von Vishal Madan. Beteiligte Einrichtung: Department of Dermatology, Northern Care Alliance NHS Foundation Trust, Salford, UK. Hauptthemen laut MEDLINE: Skin Neoplasms, Referral and Consultation, Waiting Lists, State Medicine. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although pressures on the National Health Service skin cancer services pre-dated the COVID pandemic, the 2-week-wait (2WW) skin cancer standards that require hospitals to provide an appointment with a specialist within 2 weeks for anyone with symptoms that may indicate cancer have deteriorated post the pandemic.

Objectives

To undertake process mapping of the current 2WW skin cancer pathways and provide recommendations to streamline and improve the pathway to meet the 2WW standards.

Methods

The 2WW skin cancer pathway is analysed in this report utilizing 4 V typology encompassing the four dimensions of operations: volume, variety, variation and visibility, and a volume–variety matrix. A performance matrix of the 2WW skin cancer pathway and SIPOC (suppliers, inputs, processes, outputs and customers) analysis are also examined.

Results

Process analysis enabled the identification of some of the limitations of the 2WW skin cancer pathway. Following analysis and redesign of the process map of the pathway, recommendations, including lesion assessment using artificial intelligence, single-lesion assessment clinics and direct access skin surgery, all of which aim to expedite patient care and increase capacity in 2WW clinics, are provided.

Conclusions

The process analysis of the 2WW skin cancer pathway provides useful insights and helps identify bottlenecks in the system. Recommendations following remapping the process offer potential solutions to help reduce time to referral and to increase capacity. These recommendations should help reduce waiting times for patients receiving an initial diagnosis and subsequent definitive treatment for suspected skin cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsReferral and ConsultationWaiting ListsState MedicineCOVID-19HumansUnited KingdomQuality ImprovementTime-to-TreatmentCritical PathwaysSARS-CoV-2Time Factors

Autor:innen und Institutionen

  • Department of Dermatology, Northern Care Alliance NHS Foundation Trust, Salford, UK.

Zitieren

APA

Madan, V. (2024). The National Health Service 2-week-wait skin cancer referral pathway: analysis and recommendations for process improvement. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llae323

Vancouver

Madan V. The National Health Service 2-week-wait skin cancer referral pathway: analysis and recommendations for process improvement. Clinical and Experimental Dermatology. 2024. doi:10.1093/ced/llae323

BibTeX
@article{Madan2024,
  author = {Madan, Vishal},
  title = {The National Health Service 2-week-wait skin cancer referral pathway: analysis and recommendations for process improvement},
  journal = {Clinical and Experimental Dermatology},
  year = {2024},
  doi = {10.1093/ced/llae323}
}
Kostenlos starten →